Novartis AG patent applications published on July 25th, 2024
Contents
- 1 Patent applications for Novartis AG on July 25th, 2024
- 1.1 DOSING REGIMENS (18559859)
- 1.2 DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES (17415923)
- 1.3 Tricyclic Compounds and their Uses (18483651)
- 1.4 MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 (18531320)
- 1.5 GLUCAGON LIKE PEPTIDE COMPOUNDS (18556461)
Patent applications for Novartis AG on July 25th, 2024
DOSING REGIMENS (18559859)
Main Inventor
Stephanie Kay DODD
DOSING REGIMEN AND PHARMACEUTICAL COMBINATION COMPRISING 3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES (17415923)
Main Inventor
Simone BONAZZI
Tricyclic Compounds and their Uses (18483651)
Main Inventor
Vincent BORDAS
MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF SHP2 (18531320)
Main Inventor
Zhongbo Fei
GLUCAGON LIKE PEPTIDE COMPOUNDS (18556461)
Main Inventor
Valerie BEAULIEU
